An ejection fraction below about 35% is widely considered dangerously low, and below 20% the risk of sudden cardiac death, hospitalization, and organ failure climbs steeply. A healthy adult heart typically pumps out around 60 to 65 percent of the blood filling it with each beat, so numbers in the 20s or teens represent a heart working at a fraction of its normal capacity. But the danger is not determined by the number alone. How fast the EF dropped, what caused it, and how the rest of the body is compensating all shape the outlook in ways a single percentage cannot capture.
What Counts as Normal
A large meta-analysis of population-based echocardiographic studies found that the average left ventricular ejection fraction in healthy adults is about 63%, with a normal range running roughly from the low 50s to the low 70s. Women averaged slightly higher than men (about 64% versus 62%). Fewer than one percent of healthy people fell below 50%.1PubMed Central. What is a normal left ventricular ejection fraction in healthy adults? A meta-analysis of population-based echocardiographic studies That 50% mark is the threshold below which doctors start paying close attention, because the heart is no longer squeezing with the force a healthy pump should.
How Heart Failure Is Classified by EF
Cardiologists sort heart failure into categories based on how much pumping power remains. An EF of 50% or above is called heart failure with preserved ejection fraction, meaning the heart still contracts reasonably well but has other problems, usually with stiffness or filling. An EF of 40 to 49% is classified as heart failure with mildly reduced ejection fraction, a category created to bridge the gap between the two traditional groups.2PubMed. Heart failure with mildly reduced ejection fraction (HFmrEF): where are we now? Below 40% is heart failure with reduced ejection fraction, the category that carries the most aggressive treatment recommendations and the highest risk.
Within that under-40% group, the difference between an EF of 38% and an EF of 18% is enormous. Guidelines and clinical trials often use 35% as a cutoff for device therapy decisions, and an EF below 25% flags patients who need especially close monitoring during any physical activity.3PubMed Central. Practical Guidelines for Exercise Prescription in Patients with Chronic Heart Failure So while 40% is the formal clinical threshold for “reduced,” the truly dangerous territory is a sliding scale that steepens as the number drops.
What Happens in the Body When EF Is Very Low
When the heart can only push out a small fraction of its blood volume, everything downstream suffers. The organs that need the most blood flow, including the brain, kidneys, and liver, begin to struggle. Fluid backs up into the lungs, causing shortness of breath that can become severe even at rest. Swelling in the legs and abdomen is common as the heart fails to move blood forward efficiently. Fatigue becomes relentless because muscles receive less oxygen with each heartbeat.
The body tries to compensate by ramping up stress hormones and retaining salt and water, which temporarily boosts blood pressure and cardiac output but ultimately makes things worse. Over time, these compensatory mechanisms stretch and remodel the heart, making it even weaker. At an EF below 20%, the margin for any additional insult, whether an infection, a missed medication dose, or a new irregular heartbeat, is razor thin.
What Drives EF Down to Dangerous Levels
The most common path to a dangerously low EF is damage from a heart attack. When a coronary artery becomes blocked, part of the heart muscle dies. If enough muscle is lost, the remaining tissue cannot compensate, and the EF plummets. Ischemic cardiomyopathy, the heart-muscle weakness caused by coronary artery disease, is the single most common cause of heart failure worldwide. The damage involves both irreversible loss of viable muscle from the heart attack itself and ongoing dysfunction of muscle that is still alive but chronically starved of blood flow.4PubMed Central. Ischemic Cardiomyopathy and Heart Failure After Acute Myocardial Infarction In large heart failure registries, roughly two thirds of patients with reduced EF had ischemic cardiomyopathy, while the remaining third had non-ischemic causes.5PubMed Central. Ischemic Cardiomyopathy versus Non-Ischemic Dilated Cardiomyopathy in Patients with Reduced Ejection Fraction
Non-ischemic causes include viral infections that inflame the heart muscle, chronic alcohol or drug toxicity, chemotherapy side effects, genetic conditions, and autoimmune processes. Inflammatory cardiomyopathy, for instance, results from myocarditis that leads to weakened pumping and structural remodeling of the heart.6PubMed Central. New-Onset Heart Failure From Viral Myocarditis and Inflammatory Cardiomyopathy: A Case Report Whether the cause matters for the danger level depends in part on reversibility: some non-ischemic causes can improve if the underlying trigger is removed, whereas scar tissue from a heart attack is permanent.
Sudden Cardiac Death and Rhythm Problems
A dangerously low EF does not just mean the heart pumps weakly. It also means the electrical system becomes unstable. Damaged or stretched heart muscle is prone to dangerous rhythm disturbances, particularly ventricular tachycardia and ventricular fibrillation, which can cause the heart to stop pumping entirely. In a large analysis covering decades of heart failure trials, patients who died suddenly tended to be those with worse cardiac function and more often had ischemic disease.7PubMed. Declining Risk of Sudden Death in Heart Failure
This is why an EF of 35% or below is the traditional threshold for considering an implantable cardioverter-defibrillator, or ICD, a device that monitors the heart’s rhythm continuously and delivers a shock if a lethal arrhythmia develops. For patients whose heart also beats out of sync, cardiac resynchronization therapy uses a special pacemaker to coordinate the contractions. Pooled data from clinical trials show that adding a defibrillator to resynchronization therapy lowered all-cause mortality, with the benefit especially pronounced in patients with non-ischemic cardiomyopathy and in those over 70.8Circulation. Clinical outcomes of cardiac synchronization with or without an implantable cardioverter defibrillator based on pooled data from 5 clinical trials: a patient-level meta-analysis
An important nuance is that even when EF improves after treatment, the arrhythmia risk does not vanish completely. A study tracking patients whose EF recovered found that those with improved EF had significantly fewer dangerous rhythm events than those whose EF stayed persistently low, but a small number still needed their ICD to fire. No patient whose EF recovered to 40% or above needed shock therapy during the study period.9PubMed. Left Ventricular Ejection Fraction Improvement and Ventricular Arrhythmia Risk in Patients With Heart Failure The takeaway for patients with ICDs: recovery is great news, but the risk reduction is gradual, not absolute.
Mortality Numbers and What Predicts Survival
Studies of patients with very low ejection fractions paint a sobering picture. In one cohort of heart failure patients with very low EFs, three-year mortality was 74%. Interestingly, once the EF was already severely depressed, the exact number mattered less for predicting who would die. Exercise capacity turned out to be a far stronger predictor of outcomes than the EF itself.10PubMed. Three year mortality in heart failure patients with very low left ventricular ejection fractions In other words, a patient with an EF of 15% who can still walk on a treadmill may do better than one with an EF of 25% who can barely stand.
Other factors layer on top of EF to predict survival. Low blood sodium levels, for example, independently increase the risk of death in heart failure patients after a heart attack, even after accounting for kidney function and diuretic use.11PubMed. Plasma sodium and mortality risk in patients with myocardial infarction and a low LVEF The condition of the kidneys, the presence of diabetes, age, and whether the heart failure was caused by a blockable artery or a diffuse muscle problem all shift the prognosis in ways that a single EF number cannot convey.
Perhaps the most powerful prognostic signal is whether EF improves with treatment. Among patients with reduced EF, those whose EF climbed by at least five percentage points had roughly a 38% lower risk of dying compared to non-responders. That improvement was the second strongest predictor of survival in the study, behind only kidney function at baseline.12PubMed Central. Changes in Left Ventricular Ejection Fraction Predict Survival and Hospitalization in Heart Failure With Reduced Ejection Fraction The direction of travel matters more than the starting point.
Medications That Can Turn Things Around
Modern heart failure therapy revolves around four drug classes used together, sometimes called quadruple therapy: a neurohormonal blocker that combines a neprilysin inhibitor with an angiotensin receptor blocker, a beta-blocker, a mineralocorticoid receptor antagonist, and an SGLT2 inhibitor. Getting all four classes on board quickly matters. Modeling based on clinical trial data estimates that untreated patients had a one-year death rate of about 15 per 100, while those started on an optimized quadruple therapy regimen saw that number drop to roughly 5 to 7 per 100. Heart failure hospitalizations showed a similar pattern, falling from about 32 per 100 patients untreated to around 7 to 11 per 100 with therapy.13PubMed Central. Comparison of Quadruple Therapy Sequencing Strategies for Heart Failure With Reduced Ejection Fraction
Speed of initiation also makes a difference. In a real-world study, patients who achieved all four drug classes had substantially better outcomes than those who did not. Failing to reach the full combination more than doubled the risk of hospitalization or death.14PubMed Central. Early and rapid initiation of quadruple therapy for heart failure with reduced ejection fraction: A real-world experience Barriers to reaching full therapy include low blood pressure, kidney problems, and high potassium, all of which are more common when EF is very low. But the evidence strongly favors pushing to get as close to full quadruple therapy as the patient’s body can tolerate.
Devices and Surgery for the Most Severe Cases
When medications are not enough, implantable devices and surgical options come into play. ICDs and cardiac resynchronization therapy have already been discussed, but the landscape of device therapy is vast. Recent guidelines from the American College of Cardiology and partner organizations address over 335 clinical scenarios for device therapy, covering everything from primary prevention ICDs to leadless pacemakers and cardiac contractility modulation.15PubMed Central. ACC/AHA/ASE/HFSA/HRS/SCAI/SCCT/SCMR 2025 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy, and Pacing Whether an ICD is still as beneficial for patients already on modern quadruple therapy is an active area of debate, with some experts arguing that the reduced rate of sudden death on contemporary medications may shift the calculus for who truly needs a device.16PubMed. Role of Implantable Cardioverter Defibrillator in Heart Failure With Contemporary Medical Therapy
For patients with end-stage heart failure where the EF is critically low and other treatments have failed, a left ventricular assist device can take over much of the heart’s pumping work. These mechanical pumps have improved dramatically, with significant gains in both survival and quality of life.17PubMed Central. Left Ventricular Assist Devices in the Management of Heart Failure An LVAD can serve as a bridge to heart transplant or, increasingly, as permanent destination therapy for patients who are not transplant candidates.18The VAD Journal. Left Ventricular Assist Device as Destination Therapy Heart transplantation remains the gold standard for end-stage disease, but the number of available donor hearts is severely limited, making LVADs essential for many patients.
When a Dangerously Low EF Is Temporary
Not every severely low EF reading means permanent heart damage. Several conditions can cause the heart to weaken dramatically and then recover once the trigger resolves. Takotsubo cardiomyopathy, sometimes called broken-heart syndrome, is the best-known example. Triggered by severe emotional or physical stress, it mimics a heart attack and can drive the EF down to the 20s or even lower, yet it is typically completely reversible once the acute episode passes.19PubMed. Functional recovery of regional myocardial deformation in patients with takotsubo cardiomyopathy The condition most commonly affects older women and at presentation can be very difficult to distinguish from a genuine heart attack.20PubMed Central. Takotsubo Syndrome: Pathophysiology, Emerging Concepts, and Clinical Implications
Other reversible triggers include uncontrolled rapid heart rates (tachycardia-induced cardiomyopathy), severe thyroid disease, excessive alcohol use, and certain chemotherapy drugs when caught early. The clinical challenge is identifying which patients have a reversible component and which have permanent structural damage. Even among patients whose EF recovers, there is evidence that the heart retains a biochemical profile suggesting ongoing stress, and these patients remain at risk for relapse. Current thinking favors continuing heart failure medications even after EF improves, since stopping them can lead to a decline back to dangerous levels.21JACC: Heart Failure. Heart Failure With Improved Ejection Fraction: Is it Possible to Escape One’s Past?
Exercise With a Very Low EF
You might assume that exercising with a dangerously low EF is out of the question, but the evidence says otherwise. Cardiac rehabilitation has been shown to be safe and beneficial for heart failure patients, producing meaningful improvements in quality of life, functional capacity, and heart failure hospitalizations.22PubMed. Cardiac Rehabilitation for Patients With Heart Failure: JACC Expert Panel Across more than 60,000 patient-hours of supervised exercise training in published studies, there were no deaths directly related to exercise, and the exercise groups actually had fewer combined adverse events than control groups.23Canadian Journal of Cardiology. What Is a Dangerously Low Ejection Fraction?
That said, patients with EF below 25% are flagged as higher-risk and require closer monitoring during exercise sessions, including longer periods of continuous heart rhythm tracking.3PubMed Central. Practical Guidelines for Exercise Prescription in Patients with Chronic Heart Failure The key is that the exercise needs to be supervised, structured, and prescribed by a team that knows the patient’s full clinical picture. Walking out your front door and going for a jog without medical guidance is a very different proposition from a monitored cardiac rehab program.
Measurement Can Be Imprecise
One thing patients rarely hear is how much measurement variability exists in EF readings. The most common method for estimating EF is a standard two-dimensional echocardiogram, essentially an ultrasound of the heart. Compared to cardiac MRI, which is considered the most accurate method, 2D echo underestimated EF by an average of about 3.7 percentage points, with individual readings potentially differing by as much as 18 points in either direction. At the clinically important threshold of 50%, nearly one in ten patients was classified differently by echo versus MRI.24PubMed Central. Echocardiography versus Cardiac MRI for Measurement of Left Ventricular Ejection Fraction in Individuals with Cancer and Suspected Cardiotoxicity Three-dimensional echocardiography narrowed the gap somewhat, but still showed some disagreement with MRI.
This matters because treatment decisions, including whether to implant a defibrillator, are tied to specific EF thresholds. If your echo says 34% and the true number is 38%, the clinical decision could swing either way. When a treatment decision hinges on whether you are just above or just below a cutoff, it is worth asking whether a cardiac MRI might give a more reliable answer. In practice, most patients get echo-based estimates because echocardiograms are cheaper, faster, and more widely available, but awareness of the measurement uncertainty is important.
The Right Side of the Heart Gets Overlooked
Most conversations about EF focus exclusively on the left ventricle, the chamber that pumps blood to the entire body. But the right ventricle has its own ejection fraction, and when it fails, the consequences are serious. In patients with significant tricuspid valve leakage, a right ventricular EF below 20% was associated with a three-fold increase in the risk of death or hospitalization over two years compared to those with a right ventricular EF of 20% or above.25PubMed Central. Association With Outcome of the Regurgitant-Volume Adjusted Right Ventricular Ejection Fraction in Secondary Tricuspid Regurgitation Right ventricular failure often develops as a consequence of chronic left-sided heart failure or lung disease, and it signals that the heart’s ability to maintain circulation through the lungs is collapsing.
Right ventricular EF is harder to measure than left ventricular EF because of the right ventricle’s irregular shape, and it is not routinely reported on standard echocardiograms. Cardiac MRI is the preferred method when the right ventricle is a concern. Patients with conditions like pulmonary hypertension, severe lung disease, or congenital heart defects should pay particular attention to right ventricular function, because for them, the right side of the heart may be the more critical bottleneck.
Smartwatches and Early Detection
One of the most intriguing developments is the use of consumer wearable devices to flag low EF before symptoms become obvious. A prospective study at Mayo Clinic tested whether a single-lead ECG from an Apple Watch, run through an artificial intelligence algorithm, could detect an EF of 40% or below. The algorithm performed well, with a diagnostic accuracy reflected in an area under the curve of about 0.885, meaning it correctly identified most patients with reduced pumping function while keeping false alarms reasonably low.26PubMed Central. Prospective evaluation of smartwatch-enabled detection of left ventricular dysfunction The recordings were taken in non-clinical settings, meaning patients were going about their normal daily lives.
This technology is still evolving and is not a substitute for a formal echocardiogram. But low EF is often asymptomatic in its early stages, and by the time symptoms drive someone to a doctor, the damage may already be advanced. A wearable that nudges someone to seek evaluation earlier could meaningfully change outcomes, particularly for people with risk factors like prior heart attacks, diabetes, or a family history of cardiomyopathy. The gap between “dangerously low” and “treatable” often comes down to how quickly the problem is caught.
Heart Failure in Children and Congenital Heart Disease
Everything discussed so far applies primarily to adults, and heart failure in children is a fundamentally different problem. Children with congenital heart disease develop heart failure through mechanisms that bear little resemblance to the coronary artery blockages and age-related decline seen in adults. The anatomical abnormalities specific to various congenital defects contribute to heart failure in ways that limit how directly adult treatment strategies can be applied.27Circulation. Evaluation and Management of Chronic Heart Failure in Children and Adolescents With Congenital Heart Disease: A Scientific Statement From the American Heart Association There are significant knowledge gaps in understanding heart failure staging and outcomes in this population, and the EF thresholds used to classify adult heart failure do not translate neatly to children whose hearts may have been structurally abnormal since birth. Parents of children with congenital heart disease should work with pediatric cardiologists who specialize in these unique physiology patterns rather than relying on adult-oriented EF benchmarks.